FINWIRES · TerminalLIVE
FINWIRES

Citigroup Adjusts Bristol-Myers Squibb Price Target to $66 From $64

作者

-- Bristol-Myers Squibb Company (BMY) has an average rating of overweight and mean price target of $63.57, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Price: $58.90, Change: $-1.69, Percent Change: -2.79%

相关文章